Andrew C von Eschenbach became the twelfth director of the National Cancer Institute, serving until 2006
On Jan. 22, 2002, Dr. Andrew C. von Eschenbach became the twelfth director of the National Cancer Institute…
Los Angeles Cancer Center Received $15 Million for Woman’s Health Center
On Mar. 26, 2005, The University of Southern California/Norris Comprehensive Cancer Center in Los Angeles announced a $15…
Biotechnology | Genomics | HIV | Oncology
Stanford researchers became the first to use RNAi to switch off genes in mice
In 2002, Stanford geneticist Mark Kay uses a gene-therapy technique known as RNA inhibition to switch off genes…
Stanford researchers became the first to use gene expression profiling to predict cancer outcomes
In 2002, Stanford researchers became the first to use gene expression profiling to predict cancer outcomes. The research…
The National Cancer Institute launched the National Lung Screening Trial
In 2002, the National Cancer Institute (NCI) launched the landmark National Lung Screening Trial (NLST) to determine whether…
Digital diagnostic technology developed with creation of AQUA (Automated Quantitative Analysis) at Yale Cancer Center
In 2002, digital diagnostic technology was developed with the creation of AQUA (Automated Quantitative Analysis) at Yale Cancer…
The Nevada Cancer Institute was founded
In 2002, the Nevada Cancer Institute (NVCI), founded in 2002 and located in Summerlin, was a non-profit organization…
Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania
In 2002, the Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania…
Biotechnology | Diagnostics | Disease | Medicine | Oncology | Therapeutics
The Cancer Center at Baylor College of Medicine was established
In 2002, the Cancer Center at Baylor College of Medicine, now known as the Dan L Duncan Comprehensive…
$2.5 million award from Jeld-Wen Foundation endowed OHSU Chair in Leukemia Research for Brian Druker
On Nov. 7, 2001, the Oregon Health Sciences University Foundation (OHSU) announced that the Klamath Falls-based JELD-WEN Foundation…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The National Cancer Institute launched the Consumer Advocates in Research and Related Activities program
On Sept. 10, 2001, the National Cancer Institute (NCI) launched the Consumer Advocates in Research and Related Activities…
National Cancer Institute and ACRIN launched first multicenter study to compare digital mammography
On Sept. 4. 2001, the National Cancer Institute (NCI) and the American College of Radiology Imaging Network launched…
The Alvin J Siteman Cancer Center was named a NCI Designated Cancer Center
In August 2001, the Alvin J. Siteman Cancer Center was named an National Cancer Institute (NCI) -Designated Cancer…
OMRF researchers found that BRCA1 and BRCA2 genes may predict breast cancer risk in women
On May 24, 2001, Dr. Eldon Jupe and a team of Oklahoma Medical Research Foundation (OMRF) researchers found…
The FDA approved Gleevec, developed by OHSU, for treatment of chronic myeloid leukemia
On May 10, 2001, the U.S. Food and Drug Administration (FDA) approved Gleevec, the world’s first targeted cancer…
Seattle Genetics completed its IPO
On Mar. 7, 2001, Seattle Genetics launched its IPO and sold 7 million shares at $7 per share…
The Seattle Cancer Care Alliance opened its doors
On Jan. 19, 2001, the Seattle Cancer Care Alliance outpatient clinic opened, the final phase in a more…
Livermore National Lab announced partnership with BioLuminate to develop ‘Smart Probe’ for breast cancer detection
On Jan. 10, 2001, Livermore National Laboratory announced a partnership with BioLuminate to develop ‘Smart Probe’ tool for…
Holden Cancer Center awarded NCI Comprehensive Center designation
In 2001, the Holden Cancer Center at University of Iowa received National Cancer Institute (NCI) Comprehensive Center designation….
The drug imatinib mesylate (Gleevec) was shown to be effective against chronic myelogenous leukemia
In 2001, the drug imatinib mesylate (Gleevec) was shown in a clinical trial to be effective against chronic…
Moores Cancer Center at UC San Diego achieved NCI designated comprehensive cancer center status
In 1978, Moores Cancer Center (MCC) at UC San Diego achieved National Cancer Institute (NCI) designated comprehensive cancer…
Karmanos Institute and JP McCarthy Cord Stem Cell Bank founded
In 2001, The J.P. McCarthy Cord Stem Cell Bank at the Karmanos Cancer Institute was founded as a…
The University of Minnesota Cancer Center was founded
In 2001, the University of Minnesota Cancer Center, now known as the Masonic Cancer Center, was founded. It…
Biotechnology | Diagnostics | Disease | NIH | Oncology | Rare Disease | Therapeutics
The Stephenson Cancer Center was established
In 2001, the Stephenson Cancer Center was established. Located on the University of Oklahoma (OU) Health Sciences Center…
Vanderbilt-Ingram Cancer Center earned the NCI’s highest distinction as a Comprehensive Cancer Center
In 2001, the Vanderbilt-Ingram Cancer Center (VICC) earned the National Cancer Institute’s (NCI) highest distinction as a Comprehensive…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
Dan and Nancy Evans awarded E. Donnall Thomas Medal of Achievement Medal
In 2001, the Fred Hutchinson Business Alliance announced that the 2001 E. Donnall Thomas Medal of Achievement would…
Biotechnology | Diagnostics | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health
President Bill Clinton signed into law the Semipostal Authorization Act
On Jul. 28, 2000, President Bill Clinton signed into law the Semipostal Authorization Act (P.L. 106-253), which gave…
Holden Cancer Center awarded NCI Center designation
In 2000, the Holden Cancer Center at University of Iowa received National Cancer Institute (NCI) Center designation. The…
Dendreon Corporation launched its Initial Public Offering
On Jun. 16, 2000, Dendreon announced its initial public offering of 4,500,000 shares of common stock at $10.00…
Disease | FDA | Oncology | U.S. Congress
The Supreme Court ruled the FDA does not have authority to regulate tobacco as a drug
On Mar. 21, 2000, the Supreme Court ruled 5 to 4 along ideological lines, that the U.S. Food…